ASCO 2019 | Current approaches to treating urothelial cancer

Name: Current approaches to treating urothelial cancer
Uploaded: 2019-06-02T00:00:00Z
Duration: 2 min 3 s
Description: Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, VA, discusses current approaches to treating urothelial cancer and their limitations. She specifically mentions cisplatin-based therapy and the differenced that arise when treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Jeanny Aragon-Ching • 2 Jun 2019

ASCO 2019

Genitourinary Cancer Ovarian Cancer

Jeanny Aragon-Ching, MD, FACP, of the Inova Schar Cancer Institute, Fairfax, VA, discusses current approaches to treating urothelial cancer and their limitations. She specifically mentions cisplatin-based therapy and the differenced that arise when treating ovarian cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.